Sanket Koul

The company plans to soon start the funding process for its oncology spin-off, Kaveri Therapeutics, which houses two specialised oncology programmes

Grouping eyes more collaboration on treatment TB, NCD and mental health

Kotak Realty Fund invests ₹800 crore in two luxury housing projects by Smartworld Developers in Gurugram, deepening institutional capital flows into premium residential real estate

Seven months after the national campaign was launched, Gujarat, Uttar Pradesh, Madhya Pradesh and Mizoram have achieved 100 per cent vaccination coverage

Realty firm says disputes with Orris Infrastructure over Godrej Air have been amicably settled; actions under the settlement agreement are currently being implemented

Delhi's post-liberalisation growth turned it into a services powerhouse, but housing shortages, unplanned urbanisation, pollution and infrastructure gaps continue to test the capital

Delhi needs a virtual database to consolidate land records, while transit-oriented development norms under MPD 2047 aim to simplify development near transport corridors

Pharma sales value rose to Rs 23,272 crore in August, driven by new introductions and double-digit growth in key acute and chronic therapies, even as volume growth slowed

Healthcare-focused VC fund plans to deploy seed capital exclusively through a company creation model, targeting eight to 10 startups over a four-year investment period

Maharashtra FDA conducted 104 search and seizure operations between June and August, seizing illegal drugs and cosmetics worth Rs 11.41 crore and registering 20 FIRs

Novartis doubles down on innovation in India, eyeing R&D, clinical trials and a stronger regulatory ecosystem while moving away from traditional generics

On what will make India an attractive investment destination, Love said: ''I think the number one for us to make India attractive is to create an innovative ecosystem.''

Indian Immunologicals said Abhayrab anti-rabies vaccine vials declared NSQ and misbranded by a government laboratory were not manufactured by its human health division

CDSCO expert panel grants waiver for 920 mg Ocrelizumab, subject to Roche conducting a Phase 4 clinical trial in the Indian population for proposed indications

India's proposed rules for refurbished medical device imports remain unresolved nearly a year after a government panel was formed, amid safety concerns and demand from smaller hospitals

India will anchor the core of the CoE alongside a Dallas team as CBRE targets automation of 30 critical enterprise workflows over the next nine to 12 months

The five-year lease at Greater Noida's Golden Grande commercial hub covers 1,050 basement car parks and space for five containerised EV charging stations

Court seeks reconstruction of Singh brothers' share and asset trail

The developer will acquire 84.71 acres in Najafgarh through a Rs 420.2 crore non-cash share swap, marking its first residential entry into Delhi

Low pass rate brings overseas medical training under scrutiny